Results of the study demonstrate an increased risk for adverse drug events in older adults with polypharmacy by adding COVID-19 repurposed treatments to current medication regimens.
Results of the study demonstrate an increased risk for adverse drug events in older adults with polypharmacy by adding COVID-19 repurposed treatments to current medication regimens.